This is the reason BMS and Pfizer have been willing to spend hundreds of millions in litigation defense costs to protect those formulation patents
doi: 10.1016/j.neuint.2017.05.019 23 MaaloufMSullivanPGDavisLKimDYRhoJM
Immunomodulatory Wound Repair: Comparing the Macrophage Polarizing Effects of LL-37 and BPC-157 in Dermal Research Discover the science of accelerated wound healing by comparing the unique immunomodulatory benefits of LL-37 and BPC-157
Saxenda (liraglutide) Saxenda (liraglutide) is FDA-approved for chronic weight management
GLP-1s arent our only tool
Recently, Xu Guowang, a researcher of the Biomolecular High-resolution Separation Analysis and Metabolomics Research Group of the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, and the National Cancer Institute (NCI) researcher Yang Chunzhang, have made new progress in the treatment of isocitrate dehydrogenase 1 (IDH1) mutant glioma, revealing the importance of the glutathione (GSH) metabolic pathway regulated by Nrf2, and a new strategy for the intervention of glutathione metabolism in the treatment of gliomas is proposed
